News and media

Morag Millington | 4/05/2020

The introduction of the National Disability Insurance Scheme (NDIS) has brought many positive changes for Australians living with a disability: most people can now access NDIS funding for the care, equipment and services they need. However, one group of Australians is missing out – those diagnosed with a disability when aged 65 or over.
 

Morag Millington | 3/05/2020

Today marks this start of this year's MND Week 2020.

Morag Millington | 3/04/2020

The COVID-19 pandemic is disrupting nearly all aspects of our lives. As a result, neurologists have had to significantly alter their work practices and this, in turn, may impact MND clinical trials currently underway in Australia.
 

Laura Birks | 18/03/2020

MNDRIA has awarded the 2020-22 PhD scholarships to two oustanding early career researchers from the University of Tasmania's Menzies Institute.

Carol Birks | 17/03/2020

There is currently a notification on the Therapeutic Goods Administration (TGA) website stating that riluzole (a medication that may slow the progression of MND), has a shortage of supply in Australia.

Morag Millington | 10/03/2020

We understand that many people living with MND and their carers, families and friends may be concerned about COVID-19 (coronavirus).

Morag Millington | 28/02/2020

John Costello, SLP and Director of ALS Augmentative Communication Program at Boston Children’s Hospital, will be holding a two-day interactive workshop on enhancing communication for people with MND at UTS in Sydney on 5-6 March 2020.

Morag Millington | 18/02/2020

There is currently a notification on the Therapeutic Goods Administration (TGA) website stating that riluzole (a medication that may slow the progression of MND), has a shortage of supply in Australia.

Morag Millington | 5/02/2020

Sadly, Betty Laidlaw, who lived with MND for over 30 years and, together with her husband John Laidlaw, was a generous donor to MND research, has died.

Laura Birks | 9/12/2019

The MNDRIA PhD Scholarship Top-up Grant is awarded as an incentive to an outstanding PhD student. The grant will provide a $5,000 per annum stipend for a PhD candidate, for a maximum of three years and commencing in 2020.

Applications will be accepted from PhD students who have been awarded a full PhD scholarship for biomedical or public health research in motor neurone disease. The applicant must be an Australian citizen or Australian resident. The applicant has not received PhD top-up funding from other sources.

Click here to read more information about the top-up grants. 

Applications close on January 31, 2020.